ReviewCancer cell international2025

Overcoming CAR-T bottlenecks in high-risk DLBCL: a molecular subtyping enhancement strategy.

Rubing Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.